Join Dr. David Lieb as he moderates a discussion with Dr. Jaydira Del Rivero, Chair of the MEN1 Consensus Statement Task Force, and Dr. Michelle Lundholm, Methodology Fellow, about the recently released 2025 AACE Consensus Statement on the Management of Multiple Endocrine Neoplasia, Type 1 (MEN1).This episode covers:AACE’s updated consensus statement methodology, including the new methodology fellow and patient representative rolesThe role of surgical and non-surgical management strategies for patients with different types of MEN1-related tumorsThe importance of patient values and preferences and risks/benefits of different screening modalities when determining appropriate screening frequencies for patientsCurrent gaps in the literature and future considerations for MEN1 research

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related